Literature DB >> 27423568

Vitamin D levels are not predictors of survival in a clinic population of patients with ALS.

Jiwon Yang1, Jin-Seok Park2, Ki-Wook Oh2, Seong-Il Oh3, Hyeon-Mi Park4, Seung Hyun Kim5.   

Abstract

OBJECTIVE: This study aimed to measure serum 25-hydroxyvitamin D [25(OH)D] concentrations, bone mineral density (BMD), and the parameters of bone metabolism in amyotrophic lateral sclerosis (ALS) patients, and their correlation with survival.
METHODS: We retrospectively analysed data of 100 ALS patients who consecutively visited a single referral ALS clinic between January and December 2011. Sex; age and site of symptom onset; and death were recorded. Serum 25(OH)D concentration was dichotomized as <10ng/ml and ≥10ng/ml.
RESULTS: There was absent relationship between serum 25(OH)D and concentration of bone turnover parameters or between 25(OH)D and BMD. According to the results of the Kaplan-Meier analysis with log-rank test, the survival rates of patients without (≥10ng/ml) and of those with severe vitamin D deficiency (< 10ng/ml) were not significantly different. Cox regression analysis showed that a poor prognosis was most correlated with older age at onset and bulbar onset after adjustment for all the clinical factors.
CONCLUSIONS: In conclusion, vitamin D levels were not correlated to other bone markers and survival in a clinic population of ALS patients.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Bone density; Survival; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 27423568     DOI: 10.1016/j.jns.2016.05.007

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Vitamin D in amyotrophic lateral sclerosis.

Authors:  L Libonati; E Onesti; M C Gori; Mauro Ceccanti; C Cambieri; A Fabbri; V Frasca; M Inghilleri
Journal:  Funct Neurol       Date:  2017 Jan/Mar

2.  The vitamin D activator CYP27B1 is upregulated in muscle fibers in denervating disease and can track progression in amyotrophic lateral sclerosis.

Authors:  Ying Si; Mohamed Kazamel; Yuri Kwon; Ikjae Lee; Tina Anderson; Siyu Zhou; Marcas Bamman; Derek Wiggins; Thaddaeus Kwan; Peter H King
Journal:  J Steroid Biochem Mol Biol       Date:  2020-03-03       Impact factor: 4.292

3.  Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS).

Authors:  Francesca Trojsi; Mattia Siciliano; Carla Passaniti; Alvino Bisecco; Antonio Russo; Luigi Lavorgna; Sabrina Esposito; Dario Ricciardi; Maria Rosaria Monsurrò; Gioacchino Tedeschi; Gabriella Santangelo
Journal:  Eur J Clin Nutr       Date:  2019-06-13       Impact factor: 4.016

Review 4.  Vitamin D and Neurological Diseases: An Endocrine View.

Authors:  Carolina Di Somma; Elisabetta Scarano; Luigi Barrea; Volha V Zhukouskaya; Silvia Savastano; Chiara Mele; Massimo Scacchi; Gianluca Aimaretti; Annamaria Colao; Paolo Marzullo
Journal:  Int J Mol Sci       Date:  2017-11-21       Impact factor: 5.923

Review 5.  Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives.

Authors:  Osama A Khairoalsindi; Ahmad R Abuzinadah
Journal:  Neurol Res Int       Date:  2018-08-12

Review 6.  Potential Preventive Strategies for Amyotrophic Lateral Sclerosis.

Authors:  B Kuraszkiewicz; H Goszczyńska; T Podsiadły-Marczykowska; M Piotrkiewicz; P Andersen; M Gromicho; J Grosskreutz; M Kuźma-Kozakiewicz; S Petri; B Stubbendorf; K Szacka; H Uysal; M de Carvalho
Journal:  Front Neurosci       Date:  2020-05-26       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.